» Authors » V M Perelmuter

V M Perelmuter

Explore the profile of V M Perelmuter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 333
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ponomaroyva A, Schegoleva A, Gervas P, Gerashchenko T, Pankova O, Ershov N, et al.
Bull Exp Biol Med . 2024 Jul; 177(1):93-97. PMID: 38963595
Squamous cell lung cancer (SCLC) occurs as a result of dysregenerative changes in the bronchial epithelium: basal cell hyperplasia (BCH), squamous cell metaplasia (SM), and dysplasia. We previously suggested that...
2.
Perelmuter V, Grigoryeva E, Savelieva O, Alifanov V, Andruhova E, Zavyalova M, et al.
Sci Rep . 2024 May; 14(1):12245. PMID: 38806508
Following the discovery of circulating tumor cells (CTCs) in the peripheral blood of cancer patients, CTCs were initially postulated to hold promise as a valuable prognostic tool through liquid biopsy....
3.
Ponomaryova A, Schegoleva A, Gervas P, Pancova O, Gerashchenko T, Zarubin A, et al.
Mol Biol Rep . 2023 Jul; 50(9):7941-7947. PMID: 37480511
Background: Squamous cell lung cancer (SCLC) arises from bronchial changes: basal cell hyperplasia (BCH), squamous metaplasia (SM), and dysplasia. However, the premalignant process preceding SCLC is not inevitable; it can...
4.
Grigoryeva E, Tashireva L, Alifanov V, Savelieva O, Vtorushin S, Zavyalova M, et al.
Sci Rep . 2022 Dec; 12(1):20949. PMID: 36470982
Molecular subtype of breast cancer has a great clinical significance and used as one of the major criteria for therapeutic strategy. Recently, for anticancer therapy, the trend for oncologists is...
5.
Andryukhova E, Tashireva L, Isaeva A, Vtorushin S, Zavyalova M, Perelmuter V
Bull Exp Biol Med . 2022 Oct; 173(5):575-582. PMID: 36210412
The review analyses the frequency of malignant tumors metastasizing to the spleen. The facts are presented of a higher frequency of metastasis to the spleen in the presence of multiple...
6.
Popkov A, Kulbakin D, Popkov D, Gorbach E, Kononovich N, Danilenko N, et al.
Biomed Mater . 2021 Jul; 16(5). PMID: 34229311
Composite poly-L-lactide acid-based scaffolds with hydroxyapatite (HAp) content up to 75 wt.% were fabricated via solution blow spinning. The influence of HAp concentration on structure, wettability, mechanical properties and chemical...
7.
Grigoryeva E, Savelieva O, Popova N, Cherdyntseva N, Perelmuter V
Mol Biol Rep . 2020 Sep; 47(10):8145-8157. PMID: 32929649
Metastasis is the most life-threatening event in cancer patients, so the key strategy to treat cancer should be preventing tumor spread. Predicting the site of probable hematogenous metastasis is important...
8.
Zavyalova M, Denisov E, Tashireva L, Savelieva O, Kaigorodova E, Krakhmal N, et al.
Biochemistry (Mosc) . 2019 Sep; 84(7):762-772. PMID: 31509727
Intravasation is a key step in cancer metastasis during which tumor cells penetrate the vessel wall and enter circulation, thereby becoming circulating tumor cells and potential metastatic seeds. Understanding the...
9.
Efteev L, Rodionov E, Miller S, Tuzikov S, Velichko S, Frolov I, et al.
Khirurgiia (Mosk) . 2019 Apr; (3):84-87. PMID: 30938362
The experience of video-assisted thoracoscopic interventions for thymus tumors in the Research Institute of Oncology of Tomsk National Research Medical Center is presented. We also evaluate the features of postoperative...
10.
Gerashchenko T, Denisov E, Novikov N, Tashireva L, Kaigorodova E, Savelieva O, et al.
Exp Oncol . 2018 Oct; 40(3):228-234. PMID: 30285010
Aim: To identify gene expression profiles involved in drug resistance of different morphological structures (tubular, alveolar, solid, trabecular, and discrete) presented in breast cancer. Material And Methods: Ten patients with...